Letter: hepatic steatosis in chronic hepatitis B-viral, metabolic or treatment-related? Authors' reply
- PMID: 34907560
- DOI: 10.1111/apt.16715
Letter: hepatic steatosis in chronic hepatitis B-viral, metabolic or treatment-related? Authors' reply
Comment on
-
Systematic review with meta-analysis: prevalence of hepatic steatosis, fibrosis and associated factors in chronic hepatitis B.Aliment Pharmacol Ther. 2021 Nov;54(9):1100-1109. doi: 10.1111/apt.16595. Epub 2021 Sep 1. Aliment Pharmacol Ther. 2021. PMID: 34469587
-
Letter: hepatic steatosis in chronic hepatitis B-viral, metabolic or treatment-related?Aliment Pharmacol Ther. 2022 Jan;55(1):147-148. doi: 10.1111/apt.16687. Aliment Pharmacol Ther. 2022. PMID: 34907566 No abstract available.
References
REFERENCES
-
- Morozov S, Batskikh S. Letter: hepatic steatosis in chronic hepatitis B - viral, metabolic or treatment-related? Aliment Pharmacol Ther. 2022;55:147-148.
-
- Zheng QI, Zou B, Wu Y, et al. Systematic review with meta-analysis: prevalence of hepatic steatosis, fibrosis and associated factors in chronic hepatitis B. Aliment Pharmacol Ther. 2021;54:1100-1109.
-
- Seto WK, Hui RWH, Mak LY, et al. Association between hepatic steatosis, measured by controlled attenuation parameter, and fibrosis burden in chronic hepatitis B. Clin Gastroenterol Hepatol. 2018;16:575-583.e2.
-
- Garcia-Saenz-de-Sicilia M, Duarte-Rojo A. Hepatic steatosis and its effects on fibrosis in patients with chronic hepatitis B virus infection. Clin Gastroenterol Hepatol. 2018;16:491-494.
-
- Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156:1264-1281.e4.
Publication types
MeSH terms
LinkOut - more resources
Medical